Topics Paul speaks on.

For Health & Clinical Audiences

• What CBD does — and what it doesn't do.
• CBD for sleep, pain, and anxiety: evidence vs. marketing
• The endocannabinoid system: your body already knows what CBD is
• CBD as alternative medicine: the case for taking it seriously
• CBD vs. opioids for chronic pain: what the research shows
• Drug interactions, dosing frameworks, and patient selection
• The Medicare BEI program: what it means for patients in 2026

For Industry & Policy Audiences

• Ten years in Southern Oregon hemp: what worked, what didn't
• The November 2026 federal standard: what growers need to know
• Building a CBD brand that survives regulatory headwinds
• From farm to formulation: the supply chain most brands skip
• The future of hemp as botanical medicine
• How to talk straight about CBD with a skeptical physician
• Oregon's OLCC Hemp Registry: what it means for your business